BIOMAT Database Logo BIOMAT Database Logo

Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study. 1987

W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Brooke Army Medical Center, Fort Sam Houston, TX.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003953 Diagnosis-Related Groups A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system. Case Mix,DRG,Diagnosis Related Group,Diagnosis-Related Group,Case Mixes,DRGs,Diagnostic-Related Group,Group, Diagnostic-Related,Groups, Diagnostic-Related,Diagnosis Related Groups,Diagnostic Related Group,Diagnostic-Related Groups,Group, Diagnosis Related,Group, Diagnosis-Related,Group, Diagnostic Related,Groups, Diagnosis Related,Groups, Diagnosis-Related,Groups, Diagnostic Related,Related Group, Diagnosis,Related Groups, Diagnosis
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
May 1990, Investigational new drugs,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
September 1982, Cancer treatment reports,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
December 1987, Cancer treatment reports,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
June 1991, American journal of clinical oncology,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
April 1988, American journal of clinical oncology,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
October 1990, American journal of clinical oncology,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II evaluation of ftorafur in previously untreated colorectal cancer: a Southwest Oncology Group Study.
July 1979, Cancer,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors. A Southwest Oncology Group trial.
May 1991, Investigational new drugs,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
January 1997, Investigational new drugs,
W H Harvey, and T R Fleming, and G Beltran, and J H Saiers, and N Oishi, and D D Von Hoff
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
June 1985, Cancer treatment reports,
Copied contents to your clipboard!